Equities

Jiangsu Bioperfectus Technologies Co Ltd

688399:SHH

Jiangsu Bioperfectus Technologies Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)81.50
  • Today's Change-2.57 / -3.06%
  • Shares traded705.14k
  • 1 Year change+49.82%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Jiangsu Bioperfectus Technologies Co Ltd (688399:SHH) closed at 81.50, -22.49% below its 52-week high of 105.15, set on Oct 08, 2024.
52-week range
Today
49.02Feb 06 2024105.15Oct 08 2024
Open83.27
High84.50
Low81.07
Bid81.25
Offer81.50
Previous close84.07
Average volume1.25m
Shares outstanding56.67m
Free float28.63m
P/E (TTM)--
Market cap4.76bn CNY
EPS (TTM)-2.91
CNY
Data delayed at least 15 minutes, as of Nov 14 2024.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.